1911 |
SHINE VITAMIN C 500 PLUS |
ASCORBIC ACID 175MG, SODIUM ASCORBATE 366 MG EQ. TO ASCORBIC ACID 325 MG, CALCIUM PANTOTHENATE 10MG |
CHEWABLE TABLET |
BOTTLE |
AS A DIETARY SUPPLEMENT |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 3135/08 |
28-APR-2023 |
27-APR-2026 |
View |
1912 |
SHINE VITAMIN-B COMPLEX |
RIBOFLAVINE 15MG, THIAMINE MONONITRATE 10MG, PYRIDOXINE HCL 2MG, NICOTINAMIDE 15MG, CALCIUM PANTHOTHENATE 5MG, CYANOCOBALAMIN 0.002MG |
FILM-COATED TABLETS |
BOTTLE |
FOR THE PROPHYLAXIS AND TREATMENT OF VITAMIN B-COMPLEX DEFICIENCY SUCH AS: GLOSSITIS, ANGULAR STOMATITIS, NEURITIS, ECZEMA SEBORRHOICUM |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 3132/08 |
28-APR-2023 |
27-APR-2026 |
View |
1913 |
SHINOXOL |
AMBROXOL HYDROCHLORIDE 30 MG |
TABLET |
ALU-PVC BLISTER |
MUCOLYTIC AGENT USED IN THE TREATMENT OF RESPIRATORY TRACT DISORDERS ASSOCIATED WITH VISCID MUCUS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 3002/08 |
28-APR-2023 |
27-APR-2026 |
View |
1914 |
SHINTAMET |
CIMETIDINE 400MG |
FILM-COATED TABLETS |
ALU-PVDC BLISTER |
TREATMENT OF DUODENAL AND GASTRIC ULCER, ESOPHAGEAL REFLUX DISEASE (INCLUDING HEARTBURN AND PEPTIC ESOPHAGITIS), SELECTED CASES OF PERSISTENT DYSPEPSIA AND PATHOLOGICAL HYPERSECRETORY STATES, SUCH AS THE ZOLLINGER-ELLISON SYNDROME |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 2997/08 |
28-APR-2023 |
27-APR-2026 |
View |
1915 |
SMARTT PILL 72 |
LEVONORGESTREL BP 1.5 MG |
FILM COATED TABLET |
PVC-ALU BLISTER |
EMERGENCY CONTRACEPTION WITHIN 72 HOURS AFTER AN UNPROTECTED SEXUAL INTERCOURSE OR IN CASE OF FAILURE OF A CONTRACEPTIVE METHOD. |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICAL AND DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
02 I 5057/21 |
9-JUL-2024 |
8-JUL-2027 |
View |
1916 |
TICOMA B |
EACH ML CONTAINS: TIMOLOL MALEATE BP EQ.TO TIMOLOL 5 MG, BRIMONIDINE TARTRATE INN 2 MG |
OPHTHALMIC SOLUTION |
BOTTLE |
FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INSUFFICIENTLY RESPONSIVE TO TOPICAL BETA-BLOCKER |
NULL |
MEMESCO CO.,LTD |
OPSONIN PHARMA LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
06 I 4467/18 |
03-AUG-2022 |
02-AUG-2025 |
View |
1917 |
VIRLESS |
ACYCLOVIR 50MG/G |
CREAM |
TUBE |
SKIN INFECTIONS CAUSED BY HERPES SIMPLEX VIRUS INCLUDING INITIAL AND RECURRENT GENITAL HERPES AND HERPES LABIALIS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
01 I 2864/07 |
09-JUNE-2025 |
08-JUNE-2030 |
View |
1918 |
VIRLESS TABLET 200MG |
ACYCLOVIR 200 MG |
TABLET |
ALUMINIUM FOIL |
1. INFECTIONS CAUSED BY VARICELLA-ZOSTER VIRUS. 2. SKIN AND MUCOUS MEMBRANE INFECTIONS DUE TO HERPES SIMPLEX VIRUS.3. PROPHYLAXIS OF HERPS SIMPLEX INFECTION IN PATIENTS WHO ARE IMMUNOCOMPROMISED INCLUDING THOSE WITH BONE MARROW TRANSPLANT AND LEUKEMIA. 4. SUPPRESSION OF RECURRENT HERPES SIMPLEX VIRUS INFECTION. |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
09 I 3886/13 |
08-JAN-2024 |
07-JAN-2027 |
View |
1919 |
VIRLESS TABLET 800 MG |
ACYCLOVIR 800 MG |
TABLET |
ALUMINIUM FOIL |
1. INFECTIONS CAUSED BY VARICELLA-ZOSTER VIRUS. 2. SKIN AND MUCOUS MEMBRANE INFECTIONS DUE TO HERPES SIMPLEX VIRUS.3. PROPHYLAXIS OF HERPS SIMPLEX INFECTION IN PATIENTS WHO ARE IMMUNOCOMPROMISED INCLUDING THOSE WITH BONE MARROW TRANSPLANT AND LEUKEMIA. 4. SUPPRESSION OF RECURRENT HERPES SIMPLEX VIRUS INFECTION. |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
09 I 3883/13 |
08-JAN-2024 |
07-JAN-2027 |
View |
1920 |
VOREN |
DICLOFENAC SODIUM 50MG |
ENTERIC-COATED TABLETS |
ALU-PVC BLISTER |
INFLAMMATORY AND DEGENERATIVE FORMS OF RHEUMATISM; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS AND OSTEOARTHRITIS. NON-ARTICULAR RHEUMATISM, POST-TRAUMATIC INFLAMMATION AND SWELLING |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
03 I 2751/06 |
28-APR-2023 |
27-APR-2026 |
View |